← Back to Search

Behavioral Intervention

Self-management for High Blood Pressure

N/A

Recruiting

Research Sponsored by University of Alabama, Tuscaloosa

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

History of Stroke

High blood pressure condition

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

Study Summary

This trial aims to create a self-management program for African American stroke survivors in rural Alabama. The program will focus on improving medication adherence, diet, physical activity, managing symptoms, and mental well-being.

Who is the study for?

This trial is for African American stroke survivors over the age of 50 living in rural Alabama, who have high blood pressure. Participants should be able to manage their own care and make decisions (have good cognition).Check my eligibility

What is being tested?

The study is testing a new Community Stroke Self-management Program designed to help participants better handle their medication, diet, physical activity, symptoms, and psychological stress after a stroke.See study design

What are the potential side effects?

Since this program focuses on self-management education rather than medication or medical procedures, there are no direct side effects like those seen with drugs or surgery. However, any lifestyle changes may come with adjustment challenges.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have had a stroke in the past.

Select...

I have high blood pressure.

Select...

I am 50 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Hypertension Knowledge Level Scale Test

Hypertension Self-care Activity Level Effects

Southampton Score Self Management Questionnaire

Trial Design

1Treatment groups

Experimental Treatment

Group I: Self-managementExperimental Treatment1 Intervention

This group of participants will be given education and will be taught about overcoming the barriers to a healthy lifestyle and medication adherence. No drugs or devices will be administered to the participants/

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamOTHER

1,590 Previous Clinical Trials

2,281,637 Total Patients Enrolled

University of Alabama, TuscaloosaLead Sponsor

44 Previous Clinical Trials

19,491 Total Patients Enrolled

Mudasir Andrabi, Ph DStudy DirectorThe University of Alabama

1 Previous Clinical Trials

30 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are currently enrolled as participants in this clinical trial?

"Indeed, information on clinicaltrials.gov highlights the ongoing search for suitable candidates. The trial's initial posting was recorded on January 15th, 2023, with the latest update reflecting February 1st, 2024. Enrollment of approximately 25 participants is being sought at a single designated site."

Answered by AI

Are patients currently able to participate in this ongoing research study?

"Indeed, as per clinicaltrials.gov, this particular research study is actively seeking suitable participants. Initially shared on January 15th, 2023 and most recently revised on February 1st, 2024, the trial aims to enlist a total of 25 individuals from one designated site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Community Stroke Self-management Program

2023. "Community Stroke Self-management Program". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06251128.